Melisa Wong Points Out Potential Age Bias in Active Treatment of Lung Cancer

Video

Melisa Wong lays out the findings of a study she did looking at the age of patients with recurrent lung cancer and the likelihood they were to receive active treatment.

Melisa Wong, MD, of the University of California, San Francisco, lays out the findings of a study she did looking at the age of patients with recurrent lung cancer and the likelihood they were to receive active treatment.

The study found that for every 10-year increase in age, a patient was 25% less likely to receive active care—a patient aged 70 years was 25% more likely than one aged 80 to receive active treatment for their cancer. She suggests that age bias, among other reasons, could be responsible for this gap.

Related Videos
Meaghan Mooney, B.S.N., RN, OCN, during the Extraordinary Healer interview
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
© 2024 MJH Life Sciences

All rights reserved.